Cataract
Conditions
Interventions
N3:Adenosine disodium triphosphate group:Anterior chamber perfusate containing 0.1mg/ml adenosine disodium triphosphate was used
N4-5:Adenosine disodium triphosphate group:Anterior chamber perfusate containing 0.1mg/ml adenosine disodium triphosphate was used.
N3:The control group:Conventional anterior chamber perfusate was used.
N4-5:The control group:Conventional anterior chamber perfusate was used.
Sponsors
Sichuan Academy of Medical Sciences · Sichuan Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Older than 18 years old 2. Patients with lens nucleus hardness of 3-5 according to the Emery-Little grading system, who are scheduled for cataract surgery; Patients scheduled for cataract surgery 3. The operation was successful without complications such as posterior capsule rupture 4. Participants were of any gender or race 5. Participants were required to have relatively good general health to ensure the safety and feasibility of the surgical procedure 6. Participants should be willing to undergo preoperative evaluation and cooperate with postoperative follow-up observation
Exclusion criteria
Exclusion criteria: 1. Patients with a history of severe allergies. 2. Patients with serious systemic diseases requiring general anesthesia or comfortable anesthesia. 3.Patients with history of other ocular diseases, trauma and surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endothelial cell density;Central corneal thickness; | — |
Secondary
| Measure | Time frame |
|---|---|
| Best corrected visual acuity;Intraocular pressure;Slit-lamp examination; | — |
Countries
China
Contacts
Public ContactQu Chao
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
Outcome results
None listed